NFS1 and colorectal cancer: In addition, Lin et al. in 2022 demonstrated that phosphorylated cysteine desulfurase (NFS1) could prevent PANoptosis from weakening oxaliplatin-based chemosensitivity in colorectal cancer (Lin et al. 2022).